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Objectives: This article analyses dose measurement and effective dose estimation of dental
CBCT examinations. Challenges to accurate calculation of dose are discussed and the use of
dose–height product (DHP) as an alternative to dose–area product (DAP) is explored.
Methods: The English literature on effective dose was reviewed. Data from these studies
together with additional data for nine CBCT units were analysed. Descriptive statistics,
ANOVA and paired analysis are used to characterize the data.
Results: PubMed and EMBASE searches yielded 519 and 743 publications, respectively,
which were reduced to 20 following review. Reported adult effective doses for any protocol
ranged from 46 to 1073 mSv for large fields of view (FOVs), 9–560 mSv for medium FOVs and
5–652mSv for small FOVs. Child effective doses from any protocol ranged from 13 to 769mSv
for large or medium FOVs and 7–521 mSv for small FOVs. Effective doses from standard or
default exposure protocols were available for 167 adult and 52 child exposures. Mean adult
effective doses grouped by FOV size were 212 mSv (large), 177 mSv (medium) and 84 mSv
(small). Mean child doses were 175 mSv (combined large and medium) and 103 mSv (small).
Large differences were seen between different CBCT units. Additional low-dose and high-
definition protocols available for many units extend the range of doses. DHP was found to
reduce average absolute error for calculation of dose by 45% in comparison with DAP.
Conclusions: Large exposure ranges make CBCT doses difficult to generalize. Use of DHP
as a metric for estimating effective dose warrants further investigation.
Dentomaxillofacial Radiology (2015) 44, 20140197. doi: 10.1259/dmfr.20140197
Cite this article as: Ludlow JB, Timothy R, Walker C, Hunter R, Benavides E, Samuelson DB,
et al. Effective dose of dental CBCT—a meta analysis of published data and additional data for
nine CBCT units. Dentomaxillofac Radiol 2015; 44: 20140197.
Keywords: radiation dosage; cone beam computed tomography; humans; phantoms; adult;
child
Introduction
The intent of this article is to review the literature on
dosimetry of maxillofacial CBCT imaging in dentistry.
A discussion of dose outside the context of biological
harm has little relevance to patient care; therefore, this
report focuses on effective dose, a quantity with direct
correlations to biological risk. A number of approaches
may be taken to measure dose and calculate effective
dose, and some of the advantages and disadvantages of
these are explored. Because children are at greater risk
from exposure to ionizing radiation, child and adult
doses are explored separately. Tables of published ef-
fective dose data from all protocols and equivalent dose
data from standard CBCT protocols are presented to-
gether with previously unreported data for nine CBCT
units. Finally, dose–area product (DAP) is contrasted
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with dose–height product (DHP) as a potential surro-
gate for estimating effective dose.
Is dose from maxillofacial radiographic imaging
a relevant risk?
Dentistry had an early awareness of the dangers of ex-
posure to ionizing radiation, as pioneers of radiographic
imaging such as Edmund Kells suffered carcinoma of
the hands resulting from repeated unprotected expo-
sures during imaging of their patients.1 We were warned
about the dangers of radiography to both practitioners
and patients by other pioneers such as Rollins.2 But not
all practitioners were convinced that there was a signif-
icant risk. In an exchange of letters published in suc-
cessive February 1901 issues of the weekly predecessor
to the New England Journal of Medicine, Rollins as-
sertion that “X-light kills” was rebutted by a prominent
surgeon, Ernest Codman, stating that “in careful hands,
there is no danger from the use of the X-ray to the
patient and very little to the operator.”3 Although the
scientific debate about the level of risk associated with
diagnostic imaging continues, there is substantial evi-
dence for a cumulative dose-related response to ionizing
radiation in the form of cancer developing years after
initial exposure. Some of this evidence comes from the
Life Span Study of atomic bomb survivors, a well-
documented cohort of 105,427 people exposed to a range
of doses.4 Analysis of these data and data from several
other cohorts provides good support for an increased risk
of cancer from acute exposures in a range of 10–50mSv
and chronic exposures in a range of 50–100mSv.5 This
has prompted support by the National Commission on
Radiation Protection and Measurements for a linear
extrapolation of higher dose-associated cancer risk to
lower levels of exposure: “Although other dose–response
relationships for the mutagenic and carcinogenic effects
of low-level radiation cannot be excluded, no alternate
dose–response relationship appears to be more plausible
than the linear-non-threshold model on the basis of
present scientific knowledge.”6 The Life Span Study
data also indicate a significant radiation-associated in-
crease in the risk of cancer occurring in adolescence and
young adulthood.4 Diagnostic imaging contributes to
individual and population exposures to ionizing radia-
tion, and it has been suggested that as many as 1.5–2.0%
of cancers in the USA may be related to X-ray exposure
from CT imaging.7 Recent studies have confirmed that
cancer risk extends to X-ray exposure from diagnostic
imaging of the maxillofacial complex. In a Great
Britain cohort of approximately 175,000 subjects who
were children at the time of CT head scan exposures,
cumulative doses of about 50 mGy almost tripled the
risk of leukaemia and doses of about 60 mGy almost
tripled the risk of brain cancer.8 Similar findings were
seen in an Australian cohort of 10.9 million people aged
0–19 years, where a 24% increase in cancers, including
brain cancers and leukaemia, were noted following CT
exposure. The incidence was associated with increasing
dose and young age at the time of exposure.9
CBCT is a form of CT that has been adapted to max-
illofacial imaging and has been enthusiastically embraced
by dentistry. Since its introduction in the European
market in 1996 and in the US market in 2001, 15 different
manufacturers have offered 24 CBCT models in the USA
and many more worldwide.10 CBCT use has found its
way into many aspects of general and speciality practice,
including adolescent orthodontics. Public concern about
this particular application has prompted questions from
both patients and practitioners about safe use and best
practice.11 While the risk from dentomaxillofacial imag-
ing is small for an individual, when multiplied by the large
population of patients who are exposed to diagnostic
imaging, radiation risk becomes a significant public
health issue.
Measures of exposure to ionizing radiation
Exposure is the simplest measure of radiation dose. A
variety of radiation detection devices, including ioni-
zation chambers, radiosensitive films, thermo or optical
light-stimulated luminescent dosemeters, and metal oxide-
semiconductor field-effect transistor devices may be used
to measure ionization caused by radiation. Because cal-
cified tissues absorb X-rays more effectively than do soft
tissues and because the absorption of X-rays varies sub-
stantially with the size and shape of imaged anatomy as
well as the distribution of tissues of different densities
within that anatomy, exposure in air provides a limited
and sometimes misleading indication of the energy
imparted to different tissue types and thicknesses.
Measurement of absorbed dose in specific tissues or
organs permits estimation of potential harm to a tissue
of interest. Because the absorption efficiency of the ra-
diation detection device may be different than the organ
of interest, adjustment of measured values to compen-
sate for this is necessary. For example, absorption effi-
ciency of bone may be 2–4 times greater than that of
soft tissues for average photon energies in the diagnostic
spectrum. Absorbed dose is expressed in the international
unit, gray and more commonly for diagnostic imaging in
milligray.
Equivalent dose is absorbed dose adjusted for the
attenuation characteristics of the radiation that is in-
volved. The attenuating quality of radiation has a sig-
nificant impact on biological effectiveness for cancer
induction and genetic effects. Alpha particle radiation
produces numerous ionization events over a short dis-
tance in comparison with the energy that is transferred
by an X-ray photon over the same distance. The cal-
culation of equivalent dose (HT) is the product of the
absorbed dose (DT) and a radiation-weighting factor
(wR), which accounts for relative biologic effectiveness
of the radiation. While wR for a particle radiation is 20,
the wR for X-rays is 1. It is convenient, but sometimes
confusing, that X-ray absorbed dose and equivalent
dose are the same value. Equivalent dose is expressed
in international units, sievert and again, for diagnostic
imaging, more commonly in millisievert.
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Although in some instances it is useful to consider the
biological response to an equivalent dose for a particu-
lar tissue of interest, it is often desirable to evaluate
a variety of exposures of different types and different
body areas for a collective outcome such as cancer. The
International Commission on Radiological Protection
(ICRP) has recommended a calculation called effective
dose as the preferred method for comparing risks from
different exposures to ionizing radiation. Effective dose
is a calculation that considers the most radiosensitive
tissues and organs of the body and provides a fractional
weighting reflecting the degree of sensitivity for each of
those organs. Effective dose is reported in sieverts and
for diagnostic imaging is more commonly expressed in
millisieverts or microsieverts. Effective dose is calcu-
lated using the equation: E5+wT 3HT;where E is the
summation of the products of the tissue weighting factor
(wT) and the absorbed dose within that tissue HT.
12
Because estimation of the risk of the stochastic effects of
genetic mutation and cancer formation has evolved with
additional data reported from observations of a variety
of exposed populations, the ICRP has changed the
calculation of effective dose several times. The most
recent change was in 200713 and is noteworthy because
weights of several tissues located in and around the maxi-
llofacial region were changed, and several other tissues
within this region were added to the calculation.14 Changes
in tissue weights have resulted in a 10% increase in
weight of tissues located in the maxillofacial area and a
28% increase in weight after adjusting for the distribu-
tion of tissues. Newly added tissues for effective dose
calculation that are entirely within the maxillofacial area
include oral mucosa, salivary glands and the extra-
thoracic airways.
Approaches to measuring dose—do “all roads lead
to Rome”?
The process of measuring equivalent dose and calculating
effective dose requires a real or virtual device known as
a phantom. There are numerous design variations de-
scribed in the literature or commercially available that
include differences in phantom size, material composition
and number of dosemeter locations. While all phantoms
simulate human morphology and radiation attenuation
characteristics to a varying extent, the gold standard
method of obtaining dosimetry for calculating effective
dose utilizes an anthropomorphic phantom. Alternate
techniques for calculating dose that do not use anthro-
pomorphic phantoms include CT dose index volume
(CTDIvol), dose linear product, air kerma-area prod-
uct and DAP. In a previous study comparing an an-
thropomorphic phantom and a standard acrylic cylinder
with a single ion chamber used to calculate (CTDIvol),
we demonstrated that the standard acrylic cylinder
underestimates effective dose by 38–62%.15 This un-
derestimation is in part owing to the failure to account
for scatter dose to tissues outside of the scan region.
Kerma-area product is another method that has re-
cently been used to calculate dose.16 Values reported in
the referenced study underestimate effective dose by
90–300% when compared with effective dose calculated
from anthropomorphic phantom data.17 DAP has also
been suggested as a simple approach for calculating
dose. However, our experiments with the SCANORA®
3D (Soredex, Helsinki, Finland) unit revealed an ap-
proximately three-fold change in effective dose between
various locations of the small field of view (FOV) with
no change in DAP.18 By contrast, anthropomorphic
phantoms made from materials that have similar X-ray
attenuation characteristics as human tissue and have
multiple dosemeters allow for accurate measurement of
absorbed dose. In a recent study, we confirmed that an
anthropomorphic phantom using bone equivalent ma-
terial in place of a human skeleton could provide reli-
able measures of effective dose.19 Virtual phantoms and
Monte Carlo simulation of exposure have been used in
assessment of organ dose and effective dose for a num-
ber of studies. Dose correspondence with anthropo-
morphic phantom studies is dependent on the virtual
phantom that is used as well as imaging geometry and
technical parameters. In one study comparing four dif-
ferent phantoms developed from CT data, a 70% dif-
ference in effective dose was noted for a large FOV scan
depending phantom choice.20 When a cephalometric
analysis was performed on ICRP adult male and fe-
male phantoms, a 17° downward rotation difference of
the Frankfort plane was seen in the female. This
downward rotation of the chin effectively moves the
thyroid closer to the radiation field and results in an
average of a 3.7-fold increase in female thyroid dose
for four large FOVs that were evaluated in one study.21
Similar increases are seen in oesophageal dose in this
phantom. Although the ICRP phantoms were developed
for general dosimetric applications, the inability to ad-
just phantom posture to establish a Frankfort horizon-
tal plane or any orientation other than the original
orientation used to acquire axial CT slices limits the
accuracy of these phantoms in simulations of dental
CBCT diagnostic protocols. Although virtual phan-
toms with Monte Carlo simulation hold a great deal of
promise, further attention must be given to virtual
phantom development consistent with positioning for
standard dental diagnostic protocols before this
becomes a reliable replacement for anthropomorphic
phantoms.
Even anthropomorphic phantom systems are subject
to variations in dosimetry from a variety of sources.
Intended differences in subject size and organ location
are seen when comparing child and adult phantoms.
Child phantom effective doses are approximately 36%
greater than adult phantom doses for the same im-
aging protocol.22 This difference is largely related to
the proximity of the thyroid gland to the lower border
of the mandible. Because of reduced distance between
the thyroid and the mandible in a child, direct expo-
sure of the thyroid is more likely and the intensity of
scatter radiation from jaw structures to the thyroid is
greater.22
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Use and abuse of effective dose
Effective dose was developed to provide a measure of
stochastic risks from exposures to low doses of ionizing
radiation. While developed for use in radiation protection,
it should not be applied to estimations of individual
patient risks. There are several reasons for this. Fore-
most, effective dose represents risk to a reference subject
who is an average of characteristics, including age,
gender and genetic radiation sensitivity. Another reason
is that effective dose estimation is subject to numerous
sources of uncertainty.23 Among these is the need to
extrapolate stochastic outcomes associated with higher
doses to the low doses associated with dental diagnostic
imaging. X-ray beam shape and imaging geometry for
organs partially in or just outside the beam is also es-
timated to account for as much as ±40% variation. De-
spite these limitations, effective dose is a useful metric
for comparing alternative imaging modalities or exam-
ination protocols in terms of relative risk. Employing
the same methods of dose measurement for different
examinations, units or protocols, we can evaluate which
produces a greater or lower risk. The caveat that this risk
may be greater or less depending on individual patient
characteristics makes the comparison no less valid.
Biological parameters that influence dose
A number of physical and biological parameters in-
fluence individual dose and risk. Age has a significant
impact on both. Children are physically smaller, which
places peripherally located brain and thyroid tissues
closer to the dental area that is being imaged. Even if
not directly exposed, these organs will receive increased
scatter radiation with increased proximity to the loca-
tion of the scanned volume. But children are not simply
small adults. They are also at increased risk from any
exposure to ionizing radiation owing to cellular growth
and organ development, which increases radiosensitivity
of tissues. In conjunction with a longer life expectancy
in which cancer can develop, children may be two times
or more sensitive to radiation carcinogenesis than are
mature adults.24,25 Physical differences associated with
gender are also associated with differences in risk.
Females are at significant risk for breast cancer, while
males are not. Females are at risk for ovarian cancer,
while males are at risk for prostate cancer. Because these
organs are distant from the maxillofacial area, gender
differences do not impact dose and risk estimation for
maxillofacial imaging.
Technical parameters that influence dose
Receptor technology and field of view: Multiple technical
parameters influence patient dose. Two types of receptor
technologies are used to acquire image data. Image inten-
sifiers utilize a round receptor and produce a spherical
FOV. Square or rectangular flat panel detectors are in-
corporated in many CBCT units, and these produce a
cylindrical FOV. In general, the cylindrical field is
more efficient at capturing the anatomy of the maxil-
lofacial complex when the top of the field includes the
temporomandibular joint areas. A cylindrical volume di-
ameter, which captures both temporomandibular joint and
chin anatomy will require a spherical volume diameter that
is approximately 25% larger to cover the same anatomy.
mAs: X-ray tube current (mA) and exposure time (s) are
directly proportional to dose when other factors remain
constant. The product of mA and s (mAs) is also di-
rectly proportional. For instance, doubling mAs dou-
bles dose. It should be mentioned that exposure time
may not be the same value as scanning time. Some
CBCT units produce continuous output of radiation
during scanning. For these units, scan time is equal to
exposure time. However, most detectors are unable to
record X-ray exposure during the period when the im-
age detector integrates the X-ray energy absorbed in
individual receptor pixels and transfers this signal to the
computer. Continued X-ray exposure during signal in-
tegration contributes to patient dose but adds nothing
to image formation. To eliminate this unnecessary pa-
tient exposure, many CBCT units utilize a pulsed X-ray
source, where X-ray emission is intermittently turned
off during the image acquisition process.
kVp and beam filtration: X-ray beam quality has long
been noted as a factor associated with patient dose from
diagnostic imaging. Increasing filtration of the X-ray
beam reduces patient exposure to lower energy X-ray
photons that are more likely to contribute to patient
dose without contributing to image formation.26 While
higher beam energies (kV) are associated with loss of
contrast in film-based imaging, digital imaging affords
the possibility of post-acquisition contrast enhancement.
Use of 0.4 mm of additional copper filtration in con-
junction with increased kVp was demonstrated to reduce
patient dose by an average of 43% with one unit.10 In
a study of a different manufacturer’s unit, the effective
dose for a standard exposure with an 83 8-cm FOV
was reduced 57% using 0.5 mm of additional copper
filtration when compared with the dose produced by an
earlier version of the unit.15,19
Resolution: In order to maintain adequate signal-to-
noise level, exposure must be increased as the voxel size
is reduced to create higher resolution images. This can
take place as an increase in mA or an increase in the
number of basis images that are acquired. With some
CBCT units, this choice is under operator control, but,
at other times, the unit dictates which exposure factors
may be used with different resolutions. Automatic
doubling of dose when switching from standard to
high resolution has been reported for one unit.22
Methods and materials
Systematic review of literature on CBCT and
effective dose
A systematic review of the literature concerning CBCT
dosimetry in the maxillofacial region was performed.
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A PubMed (MEDLINE) database (National Library
of Medicine, NCBI) search was performed on 11
November 2013 and updated on 26 May 2014. An
EMBASE search was also performed on 26 May 2014
by a senior librarian at the University of North Carolina
Health Science Library, Chapel Hill, NC. The strategy
to search for publications in English language indexed
in the MEDLINE database was as follows: {“Cone-Beam
Computed Tomography” [(Mesh)] OR CBCT (tw) OR
CBVT (tw) OR Cone beam computed tomography (tw)
OR Cone beam volumetric tomography (tw)} AND
[“Radiation Monitoring” (Mesh) OR “Radiation dosage”
(Mesh) OR absorbed dos* (tw) OR equivalent dos* (tw)
OR effective dos* (tw) OR dosimetry (tw)]. The strategy
to search for publications in English language indexed
in the EMBASE database was as follows: (“cone beam
computed tomography”/exp OR “cone beam computed
tomography scanner”/exp OR CBCT:ti,ab OR CBVT:
ti,ab OR “Cone beam computed tomography”:ti,ab
OR “Cone beam volumetric tomography”:ti,ab) AND
(“radiation monitoring”/exp OR “radiation dose”/exp
OR “dosimetry”/exp OR “absorbed dose”:ti,ab OR
“absorbed doses”:ti,ab OR “absorbed dosage”:ti,ab OR
“absorbed dosages”:ti,ab OR “equivalent dose”:ti,ab
OR “equivalent doses”:ti,ab OR “equivalent dosage”:ti,
ab OR “equivalent dosages”:ti,ab OR “effective dose”:
ti,ab OR “effective doses”:ti,ab OR “effective dosage”:
ti,ab OR “effective dosages”:ti,ab). The PubMed search
yielded 519 articles and the EMBASE search yielded
743 articles. Inclusion criteria for this review were all
articles published in English in the scientific literature
related to CBCT dosimetry in the maxillofacial region.
Only articles utilizing tissue weights from the 2007
ICRP recommendations for calculating effective dose
were included. The articles had to include pertinent in-
formation regarding the scanner used, FOV size and
location, exposure technique, phantom type and dose-
meter used. Articles not meeting the inclusion criteria
were excluded after downloading the references in
EndNote® (Thompson Reuters, Rochester, NY) and
reviewing the abstracts. 65 articles were initially in-
cluded and the PDF of the articles were downloaded in
EndNote and reviewed in more detail. 43 more articles
were excluded leaving 22 articles. Data from these
studies were placed in a spreadsheet for analysis. Data
identified as outliers led to the identification of meth-
odological errors resulting in the removal of two studies
and reassessment of the data. Data from 20 studies and
additional unpublished data otherwise meeting the in-
clusion criteria were ultimately tabulated and presented
in this article. Reasons for exclusion of the 43 manu-
scripts are catalogued in Table 1.
Additional dosimetry
Previously unreported data are included for nine addi-
tional CBCT units: 3D Accuitomo (J Morita, Osaka,
Japan), CS 9000 (Carestream Dental, Atlanta, GA), CS
9300 (Carestream Dental), Orthophos XG 3D (Sirona
Dental Systems, Bensheim, Germany), Galileos Comfort
Plus (Sirona Dental Systems), ProMax Mid (Planmeca
Oy, Helsinki, Finland), NewTom VGi (Cefla Dental
Group, Imola, Italy) and OP 300 Maxio (Instrumenta-
rium, Helsinki, Finland). Scanning protocols for these
units are found in Table 2.
Following previously published protocols that utilize
24 dosemeters placed in and on anthropomorphic
phantoms, dosimetry was acquired for standard imag-
ing protocols and additional protocols when available.
Head and neck phantoms replicating the radiation at-
tenuation characteristics of human tissues and anatomy
were used.15,22 The child phantom (AtomModel 706 HN;
CIRS Inc., Norfolk, VA) simulated characteristics of a
10-year-old child. An adult phantom simulated an aver-
age adult male (Atom Max Model 711 HN; CIRS Inc.).
Optically stimulated luminescent dosemeters (nano-
Dot, Landauer, Inc., Glenwood, IL) were cleared of
ambient charge prior to use, using a minimum of 12 h of
exposure to light from a florescent tube, dental radio-
graphic film view box. Dosemeters were read to record
residual baseline energy level using a portable reader
(MicroStar; Landauer, Inc.). The reader was calibrated
before use using a set of 80-kVp reference dosemeters
supplied by the manufacturer. After adjusting for in-
dividual dosemeter energy sensitivity, photon counts
were converted to dose and automatically recorded in
a database by the reader. After placement in a phantom
and exposure to the CBCT scan, dosemeters were read
three times with the reader. The modal value of the
three readings was selected as the dose of the dosemeter.
Doses were exported from the database as an Excel®
(Microsoft, Redmond, WA) spreadsheet and adjusted
for response to the estimated mean energy of the X-ray
beam using a third-order polynomial calibration curve
derived from side-by-side comparison of recorded doses
from an ion chamber and optical stimulated lumines-
cent dosemeters over a range of 80–120 kVp using an
adjustable kVp source. Beam energy adjustments
ranged from 0.97 for an 84-kVp source (mean kV5 56)
Table 1 Reasons for exclusion of 45 of 65 citations resulting from
literature search
Reason for exclusion Number
Dosimetry based on 1990 International
Commission on Radiological Protection calculation
of effective dose rather than 2007 recommendations
6
Image-guided radiation therapy device or other
non-dental unit
10
Incomplete dosimetry—multiple organs in the head
and neck area have been omitted including
remainder tissues
6
Not a dosimetry article, a review article, letter or
other secondary source
7
Technique article that does not provide information
about specific or identifiable units
3
Effective dose not reported 9
Animal study or anatomy other than maxillofacial
area
2
Foreign language with English abstract 1
Other—reported results violate dose/mAs linearity
by 33 indicating an unrecognized calculation error
1
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to 0.78 for a 120-kVp source (mean kV5 80). 2–20
exposures were utilized for each dosemeter run to pro-
vide a more reliable measure of radiation in the dose-
meters. Smaller FOVs require more exposure repetition
because more dosemeters are outside the field of direct
exposure and absorb only small quantities of scatter ra-
diation. For every scan, a scout view was also acquired.
Dosemeter values were divided by the number of scans
to determine the “exposure per examination” for each
dosemeter.
Absorbed dose for a tissue or organ used in the esti-
mation of effective dose was calculated by averaging
doses for dosemeters located within that tissue and are
reported in micrograys (mGy).22 In instances where
tissues were not fully contained within the head and
neck area, an estimation of the proportion of this tissue
within this area was used to calculate organ absorbed
dose. For skin surface, lymph nodes and muscle, an
estimate of 5% was used. For the oesophageal tract, an
estimate of 10% was used. Calculations for bone surface
and bone marrow were adjusted for calvarial, jaw or
spine location as well as phantom type (child, adult)
using estimations of Underhill et al27 for bone distri-
bution and Christy28 for marrow distribution. For bone,
a correction factor based on experimentally determined
mass energy attenuation coefficients for bone and muscle
irradiated with monoenergetic photons was applied.
Effective beam energy estimated to be two-thirds of the
peak beam energy of the CBCT unit was used to de-
termine bone/muscle attenuation ratios. A linear fit
(R25 0.996) of ratios from 40 to 80 kV from published
data29 was used to calculate bone/muscle ratio for the
CBCT unit kVp setting. Calculated values provided
bone/muscle attenuation ratios from 3.46 at 54.0 kV
(84 kV peak) to 1.97 at 80 kV (120 kV peak) for the units
and protocols investigated in this study. The products of
absorbed dose and the percentage of a tissue or organ
irradiated in the CBCT examination were used to cal-
culate equivalent dose in microsieverts (mSv). Effective
dose (E), expressed in mSv, was calculated using ICRP
2007 tissue weighting factors.13
Data analysis
Effective doses for various exposure parameters and
protocols are reported in a tabular format together with
equivalent doses from standard or default CBCT im-
aging if these were included in the publication. Means
and variance for data grouped by child or adult phan-
tom and small, medium and large FOVs are reported in
summary tables. For this manuscript, small FOVs are
defined as any field with a height#10 cm. Medium FOVs
include a range of volume heights from 10 to 15 cm.
Large FOVs have volume heights .15 cm. ANOVA is
used to distinguish differences in equivalent doses or
effective doses owing to the variables of phantom and
FOV. An additional ANOVA examines the effect of
maxillary or mandibular position on effective dose for
small FOVs. An a level of 0.05 was selected for sta-
tistical significance.
The product of salivary gland dose and the dimen-
sions of FOV (H3W) are used as a surrogate for DAP
to calculate conversion coefficients for effective dose
estimation. Similarly, the product of salivary gland dose
and volume height alone (DHP) is calculated to in-
vestigate the possible use of this metric for calculating
effective dose conversion coefficients. This is analogous
to the product of CTDI and scan length (dose–length
product) as a dose metric in CT imaging. The absolute
error between the estimated effective dose derived from
DAP and the phantom dose measurement was com-
pared with absolute error between DHP-derived dose
and phantom measurement in a matched pairs analysis.
Results
Table 3 displays exposure parameters and doses for an
adult phantom and large FOVs. Reported effective
Table 2 Units and protocols used to produce unreported dosimetry included in this manuscript
CBCT unit Manufacturer Phantom type Protocol Field of view
3D Accuitomo J Morita (Osaka, Japan) Atom child,
adult
Standard, high fidelity, high resolution,
high speed/360°, 180° scans/child,
average adult, large adult
Large, medium,
small
CS 9000 Carestream Dental (Atlanta, GA) Rando adult Standard Small
CS 9300 Carestream Dental Atom child,
adult
Standard Medium, small




Standard, high definition, endo/child,





Sirona Dental Systems Atom child,
adult
Standard, high definition/child, teen,
small adult, average adult, large adult
Medium, small
ProMax® Mid Planmeca Oy (Helsinki, Finland) Atom child,
adult
Normal, low dose, high definition/
child, adolescent, small adult, average
adult, large adult
Medium
NewTom VGi Cefla Dental Group (Imola, Italy) Rando adult Standard, high resolution Medium, small
NewTom 3G Cefla Dental Group Atom child Standard Large, medium
OP 300 Maxio Instrumentarium (Helsinki, Finland) Atom child,
adult
Standard, low dose, high definition,
endo/child, small adult, regular adult,
large adult
Medium, small
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doses from standard protocols ranged from 46 to 916mSv.
Table 4 lists doses for medium FOVs. Reported ef-
fective doses from standard protocols ranged from 47
to 560 mSv. Tables 5 and 6 provide doses for maxillary
and mandibular small FOVs, respectively. Standard
protocol doses ranged from 5 to 140 mSv for maxillary
views and from 18 to 488 mSv for views including the
mandible. Table 7 catalogues temporomandibular joint
FOVs. Table 8 combines large and medium FOVs for
child phantoms. Doses from standard protocols ranged
from 39 to 430 mSv. Tables 9 and 10 list child doses for
maxillary and mandibular small FOVs, respectively.
Maxillary effective doses from standard protocols ranged
from 16 to 177 mSv, while FOVs including the mandible
ranged from 24 to 331 mSv. Reported adult effective
doses for any protocol in Tables 3–6 ranged from 46 to
1073 mSv for large FOVs, 9–560 mSv for medium FOVs
and 5–652 mSv for small FOVs. Child effective doses
from any protocol in Tables 7–10 ranged from 13 to
769 mSv for large or medium FOVs and 5–582 mSv for
small FOVs. Although standard protocols were the focus
of this study, the included reports and additional data
provided a total of 41 large FOV protocols, 81 medium
FOV protocols and 249 small FOV protocols for adult
phantom imaging. For child imaging protocols, the
totals were 8, 35 and 103 for large, medium and small
FOVs, respectively.
Tables 11–14 provide summary data for adult and
child doses and include mean values with standard
deviations for standard or default exposure equivalent
and effective doses. Lower numbers of units with equiv-
alent doses reflect the practice of some studies that have
included fewer weighted tissues in their calculation of
effective dose or report only effective dose. Standard
adult exposure settings resulting in average adult effec-
tive doses of 212 mSv for large FOVs, 177 mSv for
medium FOVs and 84 mSv for small FOVs are found in
Table 11. Small adult FOVs producing average effective
doses of 53 mSv for maxillary views and 102 mSv for
mandibular views are seen in Table 12. Because data for
few large FOVs were found for child phantoms, large
and medium FOVs were combined in Table 13. The
average effective dose for large or medium FOVs was
175mSv. The average child effective dose for small FOVs
was 103 mSv. When child phantom small FOVs were
analysed by arch location, an average dose of 67 mSv
was seen for maxillary views and of 128 mSv was seen
for mandibular views, as seen in Table 14.
Table 15 provides p-values for an ANOVA of effec-
tive dose and equivalent doses for each of the weighted
tissues that are typically included in head and neck
dosimetry studies. The ANOVA model investigated the
effects of FOV and phantom type. Tukey honest signifi-
cant difference results are provided for FOV for sta-
tistically significant factors. With the exception of
remainder tissues, all weighted tissues and effective dose
demonstrated significantly increased dose with increased
FOV size. With the exception of thyroid dose, which was
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were seen in equivalent or effective dose owing to phan-
tom type. A separate analysis investigated dose differ-
ences related to maxillary or mandibular location for
small FOVs for child and adult phantoms. Significantly
higher doses were associated with mandibular field
positions for the oesophagus, thyroid, salivary gland and
remainder tissues as well as effective dose. Once again,
only the thyroid tissue demonstrated significantly higher
doses in child phantoms than in adult phantoms.
Distribution of mean effective dose components from
large FOV CBCT imaging of adult phantoms is displayed
graphically in Figure 1. A similar graphic for combined
large or medium FOVs is provided for child phantoms
in Figure 2. The graphics demonstrate the greater con-
tribution of thyroid exposure to effective dose in the
child (37%) than in adult (20%).
Table 16 provides summary statistics for volume DAP
and DHP and the ratios of effective dose to each of these
values. The coefficient of variation increases with re-
duction in FOV area or height. The coefficient of variation
is consistently lower for E/DHP than for E/DAP ratios
regardless of the FOV size. This suggests that FOV height
may be a better predictor of effective dose than FOV area.
Table 17 displays average absolute error between
phantom-based calculations of the effective dose and
E/DAP or E/DHP ratios as coefficients for effective dose
estimation. The magnitude of error increases as the FOV
size is reduced. The average absolute error for all vol-
umes was 35% for E/DAP and decreased to 19% for
E/DHP. This difference was statistically significant
(p, 0.0001).
Discussion
Reported dosimetry for standard CBCT exposure set-
tings demonstrated significant reductions in effective
dose associated with the use of small FOV sizes. While
a trend of dose reduction from large to medium FOVs
was seen, this was not statistically significant. The absence
of a significant dose–FOV relationship is likely related
to two factors. Increasing FOV extends anatomic cov-
erage superiorly increasing the amounts of brain and
bone coverage with little increase in exposure of other
weighted tissues. The resulting proportional increase in
effective dose is smaller than that seen when small fields
centred on the dentoalveolar area expand both crani-
ally and caudally in medium FOV volumes. The wide
range of effective doses produced using standard settings
by different CBCT units is another factor affecting the
statistical significance of differences that may be
present between medium and large FOVs. Standard
deviations associated with dose values for these volumes
were on the same order as calculated means indicating
substantial variability among devices. Although not
assessed in detail in this study, exposure variability also
increases substantially when one includes the range of
protocol options offered by many manufacturers. Doses
for the same FOV may have as much as a 15-fold dif-
ference between low-dose and high-resolution protocols.22
This study has focused on standard or default expo-
sures. These are protocols recommended by the manu-
facturer of the CBCT unit for imaging of average or
typical patients. It should be noted that manufacturers
Table 11 Average equivalent and effective doses (mSv) for an adult using standard exposure settings of dental CBCT units
Field of view size Bone marrow Bone surface Skin Oesophagus Brain Thyroid Salivary glands Remainder Effective dose
Large
Units reported 16 16 16 14 16 16 16 16 23
Mean 359 1457 189 122 2182 1130 3484 475 212
SD 428 2081 215 125 2601 1616 3465 502 212
Medium
Units reported 32 32 32 26 32 32 32 32 43
Mean 233 844 163 75 1211 762 3675 442 177
SD 240 1194 153 53 1911 657 2643 325 137
Small
Units reported 77 79 78 57 78 77 79 74 101
Mean 94 299 62 43 211 413 2259 316 84
SD 81 376 61 38 746 433 2027 295 78
SD, standard deviation.
Table 12 Small field of view (FOV)—average equivalent and effective doses (mSv) for an adult using standard exposure settings of dental CBCT
units
FOV location Bone marrow Bone surface Skin Oesophagus Brain Thyroid Salivary glands Remainder Effective dose
Maxilla
Units reported 25 27 27 20 27 25 27 25 38
Mean 85 236 53 18 153 155 1374 213 53
SD 75 215 40 13 253 104 949 155 38
Mandible
Units reported 48 48 48 36 47 48 48 47 59
Mean 100 316 61 57 112 569 2745 380 102
SD 84 388 63 41 151 477 2324 337 88
SD, standard deviation.
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may change exposures associated with the standard
designation over time. Examples of this are seen with
Iluma and CB Mercuray devices. Initially, the highest
exposure protocols were recommended for these devices.
Later, much lower exposure protocols became the rec-
ommended “standard”. This is reflected in study data
from different investigators in Table 3. While market-
ing materials were changed to reflect updated standard
protocols, the effect on selection of imaging parameters
by end users is unclear. Differences between recom-
mended use of products and actual clinical application
are not new to dental radiology. Continued use of
round cones and D-speed film by many dental practi-
tioners in the face of many years of recommendations
by the American Dental Association and the National
Commission on Radiation Protection and Measure-
ments encouraging the use of rectangular collimation
and high-speed receptors is a prominent example.44,45
Methodologic errors in dosimetry and effective
dose calculation
Regardless of the FOV size, remainder tissues accounted
for ,10% of the effective dose calculations using ICRP
199012 tissue weights.18 The brain was the only tissue
contributing significant dose in the remainder group.
Application of ICRP 200713 tissue weights resulted in
remainder doses contributing 27–42% to effective dose
depending on FOV size and location.18 Studies ex-
cluding remainder tissues from their dose calculations
significantly underestimate dose, and a number of these
were excluded from this report.46,47 A citation that did
not include oral mucosa, which was added to the re-
mainder group in the 2007 ICRP calculation of effective
dose was also excluded.48 The oral mucosa is directly
exposed in any maxillofacial CBCT scan and as a
component of the remainder group has a tissue weight
of 0.0092. This is nearly the tissue weight of the sali-
vary glands (0.01). Similarly, the extrathoracic region is
exposed in most dental CBCT scans. Together, the
contribution of these tissues to effective dose exceeds
that of the oesophagus, skin, bone surface and brain
combined and cannot be overlooked in a calculation of
stochastic risk.18
Sampling is an important component of dosimetry,
and the sampling strategy is critical to both internal
validity of a dosimetry study and its extensibility to
other studies or patient populations. One approach that
has been taken is to sample doses over a regularly spaced
grid throughout a phantom. This approach requires
many dosemeters and results in time consuming and
expensive study protocols. An additional complication
is that the tissues and organs of particular interest for
radiation biology are not uniformly distributed. A uni-
form grid of dosemeters may not coincide with the lo-
cation of a tissue of interest. An alternate approach is to
place dosemeters only in the weighted tissues used in the
calculation of the effective dose. A uniform distribution
of dosemeters within the selected tissue is still a resource
intensive choice, so efforts to strategically locate dose-
meters within a tissue such that the average dose of a
limited number of dosemeters reasonably reflects that
of a uniform distribution of dosemeters is desirable. We
have used this approach in measuring calvarial bone
and marrow doses, where a limited number of strate-
gically positioned dosemeters are used to reflect dose to
the entire skull. For tissues that are incompletely con-
tained in the maxillofacial area, sampling of the directly
exposed portion of the tissue multiplied by the percentage
of total tissue that is directly exposed provides
Table 13 Average equivalent and effective doses (mSv) by field of view (FOV) size for a 10-year-old child using standard exposure settings of
dental CBCT units
FOV size Bone marrow Bone surface Skin Oesophagus Brain Thyroid Salivary glands Remainder Effective dose
Large or medium
Units reported 13 13 13 13 13 13 13 13 18
Mean 130 448 142 79 962 1621 2918 404 175
SD 83 331 119 61 791 1148 2117 319 115
Small
Units reported 28 28 28 28 28 28 28 28 34
Mean 60 213 65 34 171 843 2388 336 103
SD 50 202 67 33 154 997 1705 238 89
SD, standard deviation.
Table 14 Small field of view (FOV)—average equivalent and effective doses (mSv) by arch for a 10-year-old child using standard exposure settings
of dental CBCT units
FOV location Bone marrow Bone surface Skin Oesophagus Brain Thyroid Salivary glands Remainder Effective dose
Maxilla
Units reported 11 11 11 11 11 11 11 11 14
Mean 34 122 100 17 250 279 2078 298 67
SD 23 89 92 13 205 190 1553 223 54
Mandible
Units reported 17 17 17 17 17 17 17 17 20
Mean 77 273 42 46 120 1207 2589 360 128
SD 57 234 28 38 82 1138 1813 251 101
SD, standard deviation.
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a reasonable estimation of organ dose. This approach is
taken with skin, muscle, bone, lymph nodes and oesoph-
agus in our studies.10,15,17,22,49 Studies that fail to account
for body-wide distributions of tissue produce over-
estimations of equivalent doses for the bone, bone
marrow, oesophagus, lymphoid tissue, muscle and skin.50,51
This error may result in a 10- to 20-fold overestimation
of specific organ dose with a concomitant exaggeration
of effective dose. The bone marrow, which varies in
quantity and distribution by patient age is accorded
different percentages for child and adult phantoms.22
The same dosemeters may be used to calculate bone and
bone marrow dose; however, it is important to account
for differences in X-ray attenuation efficiency when
calculating absorbed doses. The higher effective atomic
number of bone leads to increased photoelectric inter-
actions and increased dose to this tissue. Mass attenua-
tion coefficients for bone and soft tissue are available
from a variety of sources and are usually calculated
using mono-energetic photons beams.29 Bone/muscle
attenuation ratios can be calculated from these data.
A linear fit of ratios from 40 to 80 kV is adequate to
cover the mean beam energy range produced by CBCT
units. In our studies, the effective beam energy of the
highly filtered, low ripple, polychromatic beams used
for CBCT is estimated to be two-thirds of the peak
beam energy. Using this assumption and an equation
developed from the linear fit of monochromatic data,
bone muscle attenuation ratios from 1.97 for a peak kil-
ovoltage of 120 kVp to 3.63 for 80 kVp are used. Studies
that fail to adjust for attenuation differences of the bone
and soft tissues may underestimate bone doses by a factor
of 2–43.30,42 Examining the ratio of the bone to bone
marrow doses using the means in Table 11 suggests a range
of 3.1–4.13 average underestimation of the bone dose if
dosemeter values are not corrected for bone attenuation
efficiency. This will lead to a 2–5% underestimation of
effective dose depending on the size of the FOV.
Tissues that are completely outside the field of direct
exposure are not sampled in our dosimetry protocol.
These tissues account for 75% of the weighted tissues in
a full body exposure; however, their indirect exposure in
maxillofacial examinations accounts for ,2% of effec-
tive dose.18,51,52 Although the oesophagus is typically
outside the field of direct exposure during CBCT scans,
it is potentially exposed to scatter radiation. Because the
oesophagus surrounds an open air space, caudally di-
rected scatter photons can extend into the upper oeso-
phageal passage exposing the mucosal walls. For this
reason, an organ fraction of 10% is used in calculating
oesophageal dose. Because of the oesophagus tissue
weight of 0.04 in the calculation of the effective dose,
this organ is as or more important than skin dose. Figure 1
suggests that studies that fail to measure oesophageal dose
underestimate effective dose by as much as 2%.30
While the use of additional dosemeters in indirectly
or directly exposed tissues may increase the precision of
calculation of organ dose, it does not guarantee an















Phantom 0.0538 0.1788 0.8268 0.4821 0.6351 0.0005 0.7143 0.8926 0.6198





Large A A A A A A A A A
Medium B B A A B A A B A A
Small C C B B C B B B B
Small
FOV
Phantom 0.0406 0.2986 0.6479 0.3281 0.3009 0.0009 0.6789 0.7445 0.1706
FOV location 0.1262 0.1104 0.384 <0.0001 0.0779 <0.0001 0.0042 0.0198 0.0002
HSD, honestly significant difference.
Bold values indicated statistical significance at a, 0.05.
FOV levels not connected by the same letter (A, B, C) are significantly different.
Figure 1 Distribution of effective dose components in an adult
phantom for large field of view dental CBCT.
Figure 2 Distribution of effective dose components from large or
medium field of view CBCT imaging of a child phantom.
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increase in the accuracy of the calculation of effective
dose. Patient positioning for CBCT can vary between
devices and operators, and this can have a pronounced
effect on dose. Duplication of phantom position when
comparing dose differences owing to technique is critical if
results are to reflect differences owing to protocol rather
than confounding owing to differences in patient position.
A 10° rotation in phantom position was noted to produce
a 92% difference in dose to the thyroid.18 Similarly, while
caudal–cranial positioning differences of the FOV by a
few millimetres may be clinically acceptable, when it
results in direct exposure of the thyroid area, it can lead
to 3- to 4-fold increases in dose to the thyroid gland and
increases in effective dose by as much as 30%.53
The allure and disappointment of dose–area product
While the use of DAP has been advocated as a measure
of dose for CBCT units,54,55 its accuracy as a measure
of risk is debatable. In relating DAP to effective dose, a
conversion coefficient must be used. Using a single
CBCT device, a recent study calculated conversion co-
efficients for DAP to effective dose for large to small
FOVs and found that a 3.8-fold range of values
(0.038–0.146mSvmGy21 cm22) was required for differ-
ent field sizes and anatomic locations.36 A 7.5-fold range
of E/DAP values was calculated from the adult phan-
tom data in this study encompassing a large number
of measurements on CBCT devices of varying beam
energies. A 2.9-fold range of E/DAP values was calcu-
lated for a more limited set of child phantom data in this
study. The use of volume height in the place of pro-
jection area resulted in statistically improved accuracy
in the estimation of effective dose but still led to a range
in the conversion coefficient of 2.4-fold for adult im-
aging and a 1.7-fold range for child imaging. A best-
case scenario of using conversion factors specific for
Table 16 Dose–area product (DAP) and dose–volume height (DHP) calculations and derived conversion coefficients for calculating effective dose
derived from phantom data
Phantom FOV
Descriptive
statistic DAP (mGy cm2) DHP (mGy cm)
Conversion coefficient
E/DAP (mSv mGy21 cm22) E/DHP (mSv mGy21 cm21)
Adult Large Mean 1229 64 0.17 3.44
SD 1240 66 0.04 0.66
c.v. – – 23% 19%
Medium Mean 683 46 0.27 3.90
SD 574 36 0.08 0.78
c.v. – – 28% 20%
Small maxilla Mean 61 7 1.28 8.29
SD 55 5 0.62 2.66
c.v. – – 48% 32%
Small mandible Mean 175 18 0.87 6.63
SD 161 18 0.51 1.87
c.v. – – 59% 28%
Child Large and medium Mean 529 35 0.35 5.07
SD 362 23 0.10 0.53
c.v. – – 29% 11%
Small maxilla Mean 121 11 0.85 6.87
SD 129 8 0.42 0.74
c.v. – – 49% 11%
Small mandible Mean 153 16 1.00 8.47
SD 126 11 0.43 2.98
c.v. – – 44% 35%
c.v., coefficient of variation; E, effective dose; FOV, field of view; SD, standard deviation.
Analysis by phantom and field of view size.
Table 17 Absolute error between phantom effective dose and dose calculated with dose–area product (DAP) and dose–height product (DHP)
conversion coefficients
Field of view Phantom n Ephantom2EDAP (mSv) Ephantom2EDHP (mSv) Probability, t
Large Child – – – –
Adult 16 36.4 28.8 0.0372
Medium Child 13 32.5 15.2 0.0183
Adult 32 39.1 27.5 0.0611
Small maxilla Child 11 41.3 5.1 0.0213
Adult 31 48.2 23.0 0.0050
Small mandible Child 17 45.6 38.7 0.2851
Adult 48 56.1 25.9 <0.0001
All 168 45.7 25.1 <0.0001
% diff from E – 35% 19% –
E, effective dose.
Bold values indicated statistical significance at a, 0.05.
Dentomaxillofac Radiol, 44, 20140197 birpublications.org/dmfr
Meta analysis of CBCT dosimetry
22 of 25 JB Ludlow et al
FOV size, arch location and patient type still resulted in
an average absolute error of 35% of the calculated ef-
fective dose when using DAP. Improvement in average
absolute error to 19% was seen when volume height was
substituted for beam area. This improvement is in-
triguing as beam height may be easily substituted for
beam area in dose calculations. While dose to salivary
glands was used in this study, dose measured in air or air
kerma are typically used in DAP calculations. These
result in different numerical values for effective dose
conversion factors but could be hypothesized to provide
similar variability for DAP and DHP calculations. While
this warrants further investigation, it is apparent that
development of universal conversion coefficients to
translate simple measures of exposure to patient dose
with the goal of risk estimation is problematic.
Why does dose–height product correlate more closely
than dose–area product to effective dose?
The dimensions of the rectangular X-ray beam are
used to calculate the area portion of DAP. For a
homogenous object that is at least the size of the X-ray
beam cross section, the product of exposure and beam
area will provide a good correlation with absorbed dose.
For maxillofacial imaging, the imaged structures are
non-homogenous with respect to tissue density, the
shape of tissues imaged and the distribution of tissues
with respect to radiation sensitivity. Beams of wider
width may more than cover the horizontal dimension of
the face. The portion of the X-ray beam that extends
beyond the face increases beam area but adds negligibly
to patient dose because it exposes the patient to only
a small amount of scatter photons from the beam in-
teraction with air. The vertical dimensions of even large
FOVs rarely exceed the dimension of the maxillofacial
area. Therefore, an increase in height of the FOV al-
most always results in an increased volume of exposed
tissue. But DHP is a better correlate with effective dose
even for small FOVs. This may be explained by the
vertical distribution of radiosensitive organs. Small
amounts of direct exposure of an organ contribute more
to dose than do larger amounts of scatter radiation. For
instance, a small amount of direct exposure of the thy-
roid gland may result in a dramatic increase in both
thyroid and effective dose.53 Mandibular locations of
small FOVs provide greater exposure of the thyroid
and submandibular salivary glands than do same size
maxillary views. Increasing height of the FOV brings
new and potentially radiosensitive tissues into the
area of direct exposure, while increasing width of the
beam simply increases dose to tissues already being
exposed.
Conclusions
Given a choice, dentists prefer images with technical
factors that provide high signal-to-noise ratios and high
resolution. Dentists requesting images from an imaging
centre or providing examinations in their own offices
may not understand the risk implications of using higher
doses to obtain image volumes. If “pretty pictures” are
being obtained when a “just diagnostic” image is needed,
we are doing the patient a disservice.18 As imaging
professionals, it is our responsibility to educate our
colleagues in other specialities and general dentistry
about the risk differences between “diagnostic” and
“pretty”. This is reason enough for dosimetry research.
Recognizing that diagnostic imaging is the single greatest
source of exposure to ionizing radiation for the US
population that is controllable, the National Commission
on Radiation Protection and Measurements has in-
troduced a modification of the as low as reasonably
achievable concept. ALADA represents “as low as
diagnostically acceptable”.56 Implementation of this
concept will require evidence-based judgments of the
level of image quality required for specific diagnostic
tasks, and exposures and doses associated with this level
of quality. Little research is currently available in this
area.
For a dosimetry study reporting effective dose to be
comparable with the contemporary studies cited in this
review, it should incorporate the following elements: the
dose calculation should follow the ICRP 2007 recom-
mendations including new and adjusted tissue weights
from all weighted tissues in the head and neck area. The
location of dosemeters or points of measurement should
be specified. When an entire organ is not exposed, such
as bone or skin surface, the strategy for extrapolating
dose for the entire organ from incomplete sampling
should be described. Adjustment for the mass attenua-
tion differences of the bone and soft tissue should be
made and described. Adjustments for sensitivity of the
dosimetry system for the mean beam energy of the X-ray
source should also be described.
Dosimetry research involves many variables in addi-
tion to the examination that is being assessed. Decisions
affecting these variables may have a profound impact
on accuracy, validity and extensibility of results. Cur-
rently, anthropomorphic phantom dosimetry, when
properly executed, provides the most accurate estimation
of effective dose. Large exposure ranges make CBCT
doses difficult to generalize. The use of DAP with av-
erage conversion coefficients to calculate dose results in
significant inaccuracy. The use of DHP as a metric for
estimating effective dose improves accuracy and war-
rants further investigation.
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